156 related articles for article (PubMed ID: 10174467)
21. Clinton team works with drug companies to expand access, restrict costs.
Am J Hosp Pharm; 1993 Mar; 50(3):388, 391. PubMed ID: 8442442
[No Abstract] [Full Text] [Related]
22. Generic drugs in cardiology: will they reduce health care costs?
Pitt B
J Am Coll Cardiol; 2004 Jul; 44(1):10-3. PubMed ID: 15234397
[TBL] [Abstract][Full Text] [Related]
23. Generic drugs: international trends and policy developments in Australia.
Lofgren H
Aust Health Rev; 2004; 27(1):39-48. PubMed ID: 15362295
[TBL] [Abstract][Full Text] [Related]
24. A critical analysis of studies of state drug reimbursement policies: research in need of discipline.
Soumerai SB; Ross-Degnan D; Fortess EE; Abelson J
Milbank Q; 1993; 71(2):217-52. PubMed ID: 8510601
[TBL] [Abstract][Full Text] [Related]
25. The context for health reform in the United Kingdom, Sweden, Germany, and the United States.
Saltman RB
Health Policy; 1997 Sep; 41 Suppl():S9-26. PubMed ID: 10174476
[TBL] [Abstract][Full Text] [Related]
26. Managing prescription drug costs.
Sica JM
Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
[TBL] [Abstract][Full Text] [Related]
27. Do drug copayments work?
David J
CMAJ; 1994 May; 150(9):1491-3. PubMed ID: 8168015
[No Abstract] [Full Text] [Related]
28. Impact of health plan design and management on retirees' prescription drug use and spending, 2001.
Thomas CP; Wallack SS; Lee S; Ritter GA
Health Aff (Millwood); 2002; Suppl Web Exclusives():W408-19. PubMed ID: 12703602
[TBL] [Abstract][Full Text] [Related]
29. The scandal of generic drug pricing: drug regulation policies need review.
Meeran K; Choudhury SM; Wass J
BMJ; 2017 Feb; 356():j947. PubMed ID: 28232321
[No Abstract] [Full Text] [Related]
30. [Separate pharmaceutical budgets: skating on thin ice].
Egberts AC; de Boer A
Ned Tijdschr Geneeskd; 2010; 154(51-52):A3004. PubMed ID: 21211087
[TBL] [Abstract][Full Text] [Related]
31. German health reform compromise under attack.
Hyde R
Lancet; 2010 Sep; 376(9743):759-60. PubMed ID: 20827796
[No Abstract] [Full Text] [Related]
32. [Pharmacists want to assume penalty].
MMW Fortschr Med; 2006 May; 148(20):55. PubMed ID: 16805194
[No Abstract] [Full Text] [Related]
33. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.
Morgan SG; Agnew JD; Barer ML
Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641
[TBL] [Abstract][Full Text] [Related]
34. [We don't prescribe the most expensive drugs, but we have the lowest costs!].
Hemberg P
Lakartidningen; 2002 Mar; 99(10):1094-5. PubMed ID: 12024788
[No Abstract] [Full Text] [Related]
35. European healthcare policies for controlling drug expenditure.
Ess SM; Schneeweiss S; Szucs TD
Pharmacoeconomics; 2003; 21(2):89-103. PubMed ID: 12515571
[TBL] [Abstract][Full Text] [Related]
36. Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.
Godman B; Wettermark B; Hoffmann M; Andersson K; Haycox A; Gustafsson LL
Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):65-83. PubMed ID: 19371180
[TBL] [Abstract][Full Text] [Related]
37. Drug costs. Cost a packet.
Davies J
Health Serv J; 2000 Mar; 110(5698):suppl 11-2. PubMed ID: 11183710
[No Abstract] [Full Text] [Related]
38. Projecting future drug expenditures--1998.
Mehl B; Santell JP
Am J Health Syst Pharm; 1998 Jan; 55(2):127-36. PubMed ID: 9465976
[TBL] [Abstract][Full Text] [Related]
39. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
Kesselheim AS; Avorn J; Sarpatwari A
JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
[TBL] [Abstract][Full Text] [Related]
40. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
